HULME ALLISON 4
4 · Ventyx Biosciences, Inc. · Filed Jan 12, 2023
Insider Transaction Report
Form 4
HULME ALLISON
Director
Transactions
- Award
Stock Option (right to buy)
2023-01-11+12,880→ 12,880 totalExercise: $34.16Exp: 2033-01-11→ Common Stock (12,880 underlying)
Footnotes (1)
- [F1]One-thirty sixth (1/36th) of the Shares subject to the option will be scheduled to vest each month following the grant date, in each case subject to the reporting person continuing to be a Service Provider (as defined in the Company's 2021 Equity Incentive Plan) through the applicable vesting date.